Clinical Trial Update: Endothelial and Metabolic Effects of Glucagon-like Peptide-1 (GLP-1) in Coronary Circulation in Patients With Type 2 Diabetes Mellitus [NA]

View source ↗

Summary

A completed clinical trial assessing the effects of glucagon-like peptide-1 on endothelial function and coronary circulation in patients with Type 2 diabetes me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• glucagon-like peptide-1 (glucagon-like peptide-1)

Snippet

Sponsor: University Hospital, Gentofte, Copenhagen | Conditions: Type 2 Diabetes Mellitus | NA | Status: COMPLETED